Photodynamic therapy for bilateral and simultaneous choroidal neovascularization in stargardt disease.

Autor: Japiassú RM; From Instituto Brasileiro de Oftalmologia, Rio de Janeiro, Brazil., Moura Brasil OF, Maia HS, Maia AS, Brasil OM
Jazyk: angličtina
Zdroj: Retinal cases & brief reports [Retin Cases Brief Rep] 2008 Winter; Vol. 2 (1), pp. 9-11.
DOI: 10.1097/ICB.0b013e3180467837
Abstrakt: Background: Stargardt disease may lead to chronic destructive changes to the retinal pigment epithelium and secondarily cause a lesion in the Bruch membrane, predisposing to subsequent subretinal choroidal neovascularization (CNV).
Methods: The authors report an angiographically documented, bilateral, and simultaneous case of CNV in Stargardt disease that was successfully treated with photodynamic therapy (PDT).
Results: A 53-year-old man with unequivocal Stargardt disease presented with CNV in both eyes simultaneously. Best-corrected visual acuity was 20/30 in the right eye and 20/40 in the left eye. PDT was performed in both eyes and vision improved to 20/25 in the right eye and 20/30 in the left eye. The lesions recurred 3 months later when vision had decreased to 20/40 in the right eye and 20/60 in the left eye. Retreatment with PDT was performed in both eyes and vision improved to 20/30 in the right eye and 20/50 in the left eye. No further recurrence was observed for 4 months.
Conclusion: Considering the positive short-term outcome in this case as well as the limited data available, PDT may be considered in cases of CNV in Stargardt disease.
Databáze: MEDLINE